The CEO and MD (advertising) of healthcare advertising group Pan, Tony Yates and Ben Davies, have teamed up with former Pan Communications managing director Rachel Terry and Ethical Strategies MD Peter Carr as Solaris's four founding shareholders.
Terry and Carr, as joint MDs, run the operation on a day-to-day basis.
Yates is chairman and Davies is a board director but both continue in their Pan roles, which are unaffected by their involvement in Solaris.
Solaris launches with seven full-time staff - all of whom, except Carr, are drawn from Pan.'This is a new company. Pan Communications has effectively ceased to exist - although the name itself still exists,' said Terry.
Solaris, which operates out of the same building as Pan in Richmond-upon-Thames, has clients such as Boehringer-Ingelheim (its HIV portfolio including Viramune) and Ardana Bioscience (its testosterone replacement drug Striant SR); all clients are former Pan Communications clients.
Terry and Carr claim Solaris is 'unique' because of a 'business tool' they call Solaris Focus, which 'focuses resources where they will have the strongest impact and deliver the greatest ROI.'